Joachim Weil
Latest contributions
Renal denervation in 2024
19 Dec 2024 – From GulfPCR-GIM 2024
Join us to explore advancements in renal denervation (RDN) technology and clinical applications. This session covers radiofrequency and ultrasound approaches, mechanisms, step-by-step procedures, patient selection, and program setup, offering insights into optimizing outcomes for hypertension patients.
Please note that this Case-in-a-Box does not reflect the recording standards...
Case report: Renal denervation using ultrasound energy (uRDN)
23 Oct 2024
In this case report, we examine an advanced technique for renal denervation (RDN)—ultrasound energy—employed to manage severe hypertension in patients with complex medical histories.
Author
Case report: Renal denervation using radiofrequency energy (rRDN)
20 Sep 2024
In this case report, we examine an advanced technique for renal denervation (RDN)—radiofrequency energy—employed to manage severe hypertension in patients with complex medical histories.
Author
Get ready – how to set up a successful renal denervation programme
18 May 2023 – From EuroPCR 2023
Delve into the essentials of renal denervation. Explore current evidence, program setup strategies, and building a multidisciplinary hypertension team.
Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.
How does Paradise renal denervation fit into hypertension treatment management?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Felix Mahfoud, Philipp Lurz, Konstantinos Tsioufis and Joachim Weil in order to understand the ultrasound-based renal denervation procedure and summary of the latest clinical data, to review consensus statements and guidelines for the renal denervation therapy today, and to hear expert perspectives on how to establish...
Addressing the population question – interesting case profiles in renal denervation
Watch this session to learn about the prevalence and importance of non-adherence to hypertension medication and the role of patient preference, and to learn about renal denervation as an option for both non-adherent and high-risk patients.
Speakers: Joachim Weil, Isabella Sudano
This interview supported by Medtronic was filmed...
